series-c-plus
Stage
3
Investors
About
Carrick Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapies for aggressive and resistant forms of cancer, with a portfolio targeting CDK7 and CDK12/13 pathways.
Explore Carrick Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.